Norway· NO-ID_DF146E49-02E7-45FB-B4BA-C78080C578DA
Tecvayli
A teclistamab product containing teclistamab, registered in Norway by Janssen-Cilag International N.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Teclistamab is registered in 14 of 19 countries.
Countries holding a registration under ATC L01FX24 (teclistamab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Teclistamab · ATC L01FX24
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Teclistamab
- Manufacturer
- Janssen-Cilag International N.V.
- Country
- Norway (NO)
- ATC code
- L01FX24
- ATC class
- Teclistamab
- Defined daily dose
- 15 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_DF146E49-02E7-45FB-B4BA-C78080C578DA
- no_varenummer5291413NOK 12054.4
- gtin7323281005759
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Teclistamab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTecvayli 10 mg/mlJanssen-Cilag International
- SwitzerlandTecvayli 30 mg/3 ml, InjektionslösungJanssen-Cilag AG
- CzechiaTECVAYLIJanssen-Cilag International N.V., Beerse
- SpainTECVAYLI 10 MG/ML SOLUCION INYECTABLEJanssen-Cilag International N.V
- IcelandTecvayliJanssen-Cilag International NV*
- PolandTECVAYLIJanssen-Cilag International N.V.
- SwedenTecvayli 10 mg/ml Injektionsvätska, lösningJanssen-Cilag International NV
- FinlandTECVAYLIOrifarm Oy
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Tecvayli
- Liechtenstein · Tecvayli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5a68d134-c67b-47b4-b033-3b49a57bbbec GET /v1/drugs/5a68d134-c67b-47b4-b033-3b49a57bbbec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Teklistamab",
"merkevare_id": "ID_DF146E49-02E7-45FB-B4BA-C78080C578DA",
"name_form_strength": "Tecvayli inj, oppl 10 mg/ml",
"prescription_group": "C"
}See everything about teclistamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.